Here are four notes:
1. EndoChoice currently has a consensus rating of “buy” and an average target price of $16.31.
2. The company has a one-year low of $3.70 and a one-year high of $19.69.
3. The firm has a 50-day moving average of $5.03 and a 200-day moving average of $9.44.
4. EndoChoice’s market capitalization is $117.28 million.
More articles on GI/endoscopy:
GI physician leader to know: Dr. Neena Abraham of Mayo Clinic
5 most read GI/endoscopy stories: Week of Feb. 29 – March 4
St. Francis Regional, Ridgeview medical centers come together for GI care: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
